AVE 25.0% 0.3¢ avecho biotechnology limited

strong open, page-3

  1. 5,322 Posts.
    I cannot for the life of me fathom why anyone would be selling today with the AOD Focus group results ( among many anncmts) due now.

    What will a success with AOD trials mean for POHs business plan, near term revenues and sp? ...if the trials show effective reduction in cellulite across the trial group- POH is surely worth more than 12cts per share?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.